These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7745436)

  • 1. Identification of high versus lower risk clinical subgroups in a group of adult patients with supratentorial anaplastic astrocytomas.
    Decaestecker C; Salmon I; Camby I; Dewitte O; Pasteels JL; Brotchi J; Van Ham P; Kiss R
    J Neuropathol Exp Neurol; 1995 May; 54(3):371-84. PubMed ID: 7745436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables.
    Decaestecker C; Salmon I; Dewitte O; Camby I; Van Ham P; Pasteels JL; Brotchi J; Kiss R
    J Neurosurg; 1997 Mar; 86(3):532-7. PubMed ID: 9046312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.
    Decaestecker C; Camby I; Nagy N; Brotchi J; Kiss R; Salmon I
    Brain Pathol; 1998 Jan; 8(1):29-38. PubMed ID: 9458164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients.
    Salmon I; Kiss R; Dewitte O; Gras T; Pasteels JL; Brotchi J; Flament-Durand J
    Cancer; 1992 Jul; 70(2):538-46. PubMed ID: 1319820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors.
    Kiss R; Dewitte O; Decaestecker C; Camby I; Gordower L; Delbecque K; Pasteels JL; Brotchi J; Salmon I
    Am J Clin Pathol; 1997 Mar; 107(3):321-31. PubMed ID: 9052383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins.
    Camby I; Nagy N; Lopes MB; Schäfer BW; Maurage CA; Ruchoux MM; Murmann P; Pochet R; Heizmann CW; Brotchi J; Salmon I; Kiss R; Decaestecker C
    Brain Pathol; 1999 Jan; 9(1):1-19. PubMed ID: 9989446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic biopsies from astrocytic tumors. Diagnostic information contributed by the quantitative chromatin pattern description.
    Salmon I; Rorive S; Camby I; Decaestecker C; Pirotte B; Rombaut K; Haot J; Pasteels JL; Brotchi J; Kiss R
    Anal Quant Cytol Histol; 1995 Oct; 17(5):332-43. PubMed ID: 8534336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.
    Decaestecker C; Camby I; Gordower L; Dewitte O; Cras P; Martin JJ; Pasteels JL; Van Ham P; Brotchi J; Kiss R; Salmon I
    J Neuropathol Exp Neurol; 1998 Aug; 57(8):791-802. PubMed ID: 9720494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms.
    Montine TJ; Bruner JM; Vandersteenhoven JJ; Dodge RK; Burger PC
    Diagn Mol Pathol; 1994 Dec; 3(4):240-5. PubMed ID: 7866633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between IDH1 mutation and prognosis in supratentorial high-grade astrocytomas].
    Xie F; Tang JJ; Wang X; Liu YH; Mao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 44(2):184-7, 192. PubMed ID: 23745251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
    Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of adult supratentorial astrocytomas: an attempt of semi-automatic grading.
    Mihara F; Numaguchi Y; Rothman M; Sato S; Fiandaca MS
    Radiat Med; 1995; 13(1):5-9. PubMed ID: 7597207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the pathological grade of astrocytic gliomas using an MRI score.
    Asari S; Makabe T; Katayama S; Itoh T; Tsuchida S; Ohmoto T
    Neuroradiology; 1994 May; 36(4):308-10. PubMed ID: 8065577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined use of the decision tree technique and the computer-assisted microscope analysis of feulgen-stained nuclei as an aid for astrocytic tumor aggressiveness characterization.
    Decaestecker C; Camby I; Salmon I; Brotchi J; Pasteels J; Kiss R; Vanham P
    Int J Oncol; 1995 Jul; 7(1):183-9. PubMed ID: 21552825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted discrimination of glioblastomas.
    Scarpelli M; Montironi R; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence of new diagnostic and prognostic human astrocytoma tumor markers. Potential therapeutic applications. I].
    Salmon I
    Bull Mem Acad R Med Belg; 1998; 153(3):199-207. PubMed ID: 9760761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.